Your solution is valuable.
‍But no one sees the same value.

The problem is real. What’s hard is that every stakeholder defines value differently. If your growth depends on navigating that complexity deal by deal, it doesn’t scale. And what doesn’t scale doesn’t exit well.

Find out where your growth is breaking

The reality of age tech today

The buyer is rarely the end user, and often isn’t the most influential decision-maker
Value differs significantly across caregivers, providers, payers, and families
Sales cycles require multi-stakeholder alignment most GTM systems aren’t built for
Customization creeps in as a workaround, replacing scalability with relationship dependency
Fragmented buying creates inconsistent growth that’s hard to explain to investors

If any of this is true, you have a scalability gap:

Your message changes depending on who’s in the room
Sales cycles are long and outcomes are unpredictable
Growth depends heavily on individual relationships and local champions
Deals stall when the stakeholder who says yes isn’t the one who controls budget

Where growth breaks

Age tech sits inside one of the most fragmented buying environments in healthcare. Families, caregivers, health systems, payers, and government programs — each with different definitions of value and different decision timelines. No single message works for all of them.

Most companies respond by customizing. A different pitch for each audience, a different proof point for each stakeholder. It creates short-term traction and long-term drag. From a buyer’s perspective, it signals a business that can’t scale without the people who built it.

What looks like a sales problem is almost always a structural one. More salespeople and more messaging don’t fix it. A commercial system that works across stakeholders without fragmenting does.

What buyers are really evaluating

Who actually pays, and why does that decision hold across accounts?
Can this scale without heavy customization for each new customer?
Does the value story translate consistently across stakeholder groups?
Is growth repeatable, or does it depend on individual champions?
What happens to retention when a key relationship leaves?

Interesting solution.
Difficult to scale.

That’s the perception when fragmented buyers can’t find a consistent story to trust.

How we help: Speed. Clarity. Impact.

We bring both professional expertise and lived experience to age tech.

Our work builds the commercial architecture that lets complex solutions scale without losing credibility with the stakeholders who matter most.

Clarify your narrative across stakeholders

Build one core positioning that adapts for each audience without fragmenting. Different buyers need different emphasis.

Build proof that different buyers trust

Align clinical, economic, and user value into evidence that resonates across the decision-making chain, without requiring a custom case for every deal.

Make growth repeatable and transferable

Reduce dependence on individual relationships and local champions by building GTM systems that work consistently at scale and hold up under diligence.

Why Legacy DNA

Deep experience in multi-stakeholder healthcare markets — we understand fragmented buying at the structural level.
Built around buyer decision-making reality, not internal assumptions about what should work.
We’ve turned “interesting solution, hard to scale” into businesses buyers can confidently acquire.
Senior-led throughout. We don’t delegate the work that matters.
ParcelShield Growth Story
A company across fragmented stakeholders where unified positioning reduced friction, shortened sales cycles, and improved scalability.
→ View the full story

Who this is for

Strong fit

Mid-market age tech companies scaling beyond early traction
B2B or B2B2C models with complex, multi-stakeholder buying groups
Leadership teams dealing with long sales cycles or inconsistent growth
PE-backed platforms where scalability and transferability are under scrutiny

Not a fit

Early-stage companies still validating demand
Teams looking for more sales activity rather than structural clarity
Organizations whose growth model is intentionally relationship-driven and not built to scale

Find out where your business is being discounted

In 30 minutes, we’ll show you exactly where buyers lose confidence and where clarity could change the outcome. We’ll identify where your story breaks across stakeholder groups, surface the scalability gap most likely to appear in diligence, and show you where alignment could make growth more repeatable.
Book my Strategic Fit Call

FAQs

01

Why is it hard to scale an age tech company despite strong market demand?
Because demand is fragmented. Age tech solutions serve multiple stakeholders with different definitions of value. If your positioning doesn’t translate across those groups, growth slows even when the need is high.

02

Who are the typical buyers in age tech, and why does that complexity matter?
Buyers include caregivers, families, providers, payers, and partners — each evaluating your solution differently. Companies that succeed build a core narrative that adapts across stakeholders rather than customizing endlessly for each one.

03

Why are sales cycles so long in age tech?
Multiple stakeholders increase decision complexity. Each layer adds proof requirements and internal alignment needs. Without a unified narrative that travels well, deals take longer and stall more often.

04

How do you make growth more predictable in age tech?
Consistent positioning, proof that holds across stakeholder groups, and a GTM system that reduces dependence on individual relationships. Predictability comes from structural alignment — not more activity.

05

What do investors look for in age tech companies?
Scalable growth, not just strong demand. Clear positioning, a repeatable sales motion, and reduced founder dependence. Fragmented narratives and inconsistent growth patterns lower confidence and compress valuation.